ACTIVE

Perrigo Europe Invest

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result40,9 M €-5,7 %over 1 year

Equity1,7 Md €+0,1 %over 1 year

Identity

Source · BCE/KBO

Perrigo Europe Invest is a Public limited company incorporated in 1989. Its registered office is in Gent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0439.658.834
Incorporation: 20/12/1989
Legal form: Public limited company
Registered office: Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map
Contributed capital: 1 623 649 604,00 €
Latest accounts: 31/12/2025

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflow

Financials

Source · NBB, 25 filings

Trend over 19 financial years

	2025		2023		2022		2021		2020
Income statement
Gross margin	–		–		–		–		–
EBITDA	-63,8 k €	-270%	-17,3 k €	+52.1%	-36 k €	-66.5%	-21,6 k €	+58.0%	-51,4 k €
Operating result	-63,8 k €	-270%	-17,3 k €	+52.1%	-36 k €	-66.5%	-21,6 k €	+58.0%	-51,4 k €
Net result	40,9 M €	-5.7%	43,4 M €	-14.1%	50,5 M €	+13.0%	44,7 M €	+14360%	-313,3 k €
Balance sheet
Equity	1,7 Md €	+0.1%	1,7 Md €	+0.0%	1,7 Md €	+20.1%	1,4 Md €	-1.1%	1,4 Md €
Total assets	1,7 Md €	-0.1%	1,7 Md €	+0.3%	1,7 Md €	+19.9%	1,4 Md €	+0.0%	1,4 Md €
Cash	–		–		–		–		–
Debts	39,5 M €	-8.1%	43 M €	+13.7%	37,8 M €	+13.5%	33,3 M €	+85.1%	18 M €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

more than 1.000 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 19 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jonas Dhaenens	Director22/05/2026 → 13/05/2032
Sonia Hollies	Director13/05/2024 → 09/05/2030
Magali Verbraeken	Director27/01/2023 → 10/05/2029
Anja van Winsberghe	Director07/05/2021 → 13/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Christophe Van Damme	Director12/05/2022 → 28/02/2023
Gianluca Parola	Director29/07/2021 → 13/05/2027
Patrick O' Sullivan	Director14/05/2020 → 29/07/2021

Other companies at this address

Gaston Crommenlaan 6 9050 Gent

Company	CBE no.
BRAVX● Active	0834.939.871
LIGHTHOUSE INTELLIGENCE● Active	0676.420.293
Oce-Bio● Active	0442.861.022
omega pharma group● Active	0837.048.632
OMEGA PHARMA INNOVATION & DEVELOPMENT● Active	0884.084.724
OMEGA PHARMA INTERNATIONAL● Active	0807.596.363
OMEGA PHARMA TRADING● Active	0417.092.080
Perrigo Belgium● Active	0417.132.860
Perrigo Capital● Active	0430.784.027
Perrigo Holding● Active	0431.676.229
TM BRAVO4 CIVIEL● Active	0787.232.501
TM BRAVO-4 KOEPEL-EPC● Active	1008.974.796
TM Goedingebrug● Active	1039.143.281
TM Nieuwe Waasmunsterbrug over Durme● Active	1035.016.328

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	18/06/2025	22/05/2024	25/05/2023	17/06/2022	14/06/2021
General meeting	29/06/2026	20/05/2025	19/04/2024	11/05/2023	12/05/2022	17/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 25 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/06/2026	07/07/2026	Dutch	PDF
Full model	31/12/2024	20/05/2025	18/06/2025	Dutch	PDF
Full model	31/12/2023	19/04/2024	22/05/2024	Dutch	PDF
Full model	31/12/2022	11/05/2023	25/05/2023	Dutch	PDF
Full model	31/12/2021	12/05/2022	17/06/2022	Dutch	PDF
Full model	31/12/2020	17/05/2021	14/06/2021	Dutch	PDF
Full model	31/12/2019	14/05/2020	11/06/2020	Dutch	PDF
Full model	31/12/2018	09/05/2019	24/05/2019	Dutch	PDF
Full model	31/12/2017	24/04/2018	24/05/2018	Dutch	PDF
Full model	31/12/2016	16/05/2017	13/06/2017	Dutch	PDF
Consolidated accounts	31/12/2016	16/05/2017	19/06/2017	Dutch	PDF
Full model	31/12/2015	20/05/2016	17/06/2016	Dutch	PDF
Consolidated accounts	31/12/2015	22/07/2016	27/07/2016	Dutch	PDF
Full model	31/12/2014	28/04/2015	27/05/2015	Dutch	PDF
Consolidated accounts	31/12/2014	28/04/2015	27/05/2015	Dutch	PDF
Full model	31/12/2013	22/04/2014	12/05/2014	Dutch	PDF
Consolidated accounts	31/12/2013	22/04/2014	12/05/2014	Dutch	PDF
Full model	31/12/2012	26/06/2013	15/07/2013	Dutch	PDF
Consolidated accounts	31/12/2012	26/06/2013	12/07/2013	Dutch	PDF
Abridged model	31/12/2011	27/06/2012	10/07/2012	Dutch	PDF
Abridged model	31/12/2010	29/06/2011	26/07/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	30/08/2010	Dutch	PDF
Abridged model	31/12/2008	24/06/2009	29/09/2009	Dutch	PDF
Abridged model	31/12/2007	16/07/2008	20/08/2008	Dutch	PDF
Abridged model	31/12/2006	18/07/2007	17/08/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 19 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Jonas Dhaenens	Director22/05/2026 → 13/05/2032
Sonia Hollies	Director13/05/2024 → 09/05/2030
Magali Verbraeken	Director27/01/2023 → 10/05/2029
Anja van Winsberghe	Director07/05/2021 → 13/05/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Christophe Van Damme	Director12/05/2022 → 28/02/2023
Gianluca Parola	Director29/07/2021 → 13/05/2027
Patrick O' Sullivan	Director14/05/2020 → 29/07/2021

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates08/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Registered office07/03/2024
MAATSCHAPPELIJKE ZETEL
PDF
Mandates09/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares15/07/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - KAPITAAL - AANDELEN
PDF
Mandates16/06/2022
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Jonas Dhaenens

Sonia Hollies

Magali Verbraeken

Anja van Winsberghe

Christophe Van Damme

Gianluca Parola

Patrick O' Sullivan

BRANDRACER

Svend Andersen

Christophe Tans

Sharon Kochan

Louis Cherico

and 11 more mandates

19891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029203020312032

Perrigo Europe InvestOMEGA PHARMA INVESTCOUCKINVEST

Gaston Crommenlaan 6 bte 606, 9050 Ledeberg (Gent)Venecoweg 26, 9810 Nazareth-De Pinte

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Gaston Crommenlaan 6 bte 606, 9050 Ledeberg (Gent)Current	accounts 2023 → 2025	Accounts 2025 · 2026-00276407
Venecoweg 26, 9810 Nazareth-De Pinte	accounts 2021 → 2022	Accounts 2022 · 2023-00100625

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Perrigo Europe InvestCurrent	accounts 2018 → 2025	Accounts 2025 · 2026-00276407
OMEGA PHARMA INVEST	accounts 2012 → 2017	Accounts 2017 · 2018-14000305
COUCKINVEST	accounts 2006 → 2011	Accounts 2011 · 2012-27700298

Events

22/05/2026
nominationJonas Dhaenens · bestuurder
2025
Annual accounts 202540,9 M €↓
20/05/2025
nominationBDO Bedrijfsrevisoren BV · commissaris
13/05/2024
nominationSonia Hollies · bestuurder
19/04/2024
nominationPaul Eelen · commissaris
2023
Annual accounts 202343,4 M €↓
27/01/2023
nominationMagali Verbraeken · bestuurder
2022
Annual accounts 202250,5 M €↑
14/06/2022
augmentation_capital
12/05/2022
nominationChristophe Van Damme · bestuurder
12/05/2022
reconductionSvend Andersen · bestuurder
2021
Annual accounts 202144,7 M €↑
2020
Annual accounts 2020-313,3 k €↑
2019
Annual accounts 2019-4,4 M €↑
2018
Annual accounts 2018-5,1 M €↑
2018
Name changePerrigo Europe Invest
2017
Annual accounts 2017-15,2 M €↑
2016
Annual accounts 2016-15,6 M €↓
2015
Annual accounts 201529,5 M €↓
2014
Annual accounts 201438,6 M €↑
2013
Annual accounts 201334,9 M €↓
2012
Annual accounts 201237,9 M €↑
2012
Name changeOMEGA PHARMA INVEST
2011
Annual accounts 201113,3 M €↑
2010
Annual accounts 20106,5 M €↓
2009
Annual accounts 20097,8 M €↑
2008
Annual accounts 20082 M €↓
2007
Annual accounts 200732,9 M €↑
2006
Annual accounts 200612 M €
20/12/1989
IncorporationPublic limited company

Perrigo Europe Invest

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events